https://scholars.lib.ntu.edu.tw/handle/123456789/433949
標題: | Position paper for the organization of ECMO programs for cardiac failure in adults | 作者: | Abrams D. Garan A.R. Abdelbary A. Bacchetta M. Bartlett R.H. Beck J. Belohlavek J. YIH-SHARNG CHEN Fan E. Ferguson N.D. Fowles J.-A. Fraser J. Gong M. Hassan I.F. Hodgson C. Hou X. Hryniewicz K. Ichiba S. Jakobleff W.A. Lorusso R. MacLaren G. McGuinness S. Mueller T. Park P.K. Peek G. Pellegrino V. Price S. Rosenzweig E.B. Sakamoto T. Salazar L. Schmidt M. Slutsky A.S. Spaulding C. Takayama H. Takeda K. Vuylsteke A. Combes A. Brodie D. for The International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO) |
關鍵字: | Cardiac arrest; Cardiac failure; Critical care networks; Extracorporeal life support; Extracorporeal membrane oxygenation; Hospital organization; Mechanical circulatory support; Position article | 公開日期: | 2018 | 出版社: | Springer Verlag | 卷: | 44 | 期: | 6 | 起(迄)頁: | 717-729 | 來源出版物: | Intensive Care Medicine | 摘要: | Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure in adult patients. Indications for ECMO use in cardiac failure include severe refractory cardiogenic shock, refractory ventricular arrhythmia, active cardiopulmonary resuscitation for cardiac arrest, and acute or decompensated right heart failure. Evidence is emerging to guide the use of this therapy for some of these indications, but there remains a need for additional evidence to guide best practices. As a result, the use of ECMO may vary widely across centers. The purpose of this document is to highlight key aspects of care delivery, with the goal of codifying the current use of this rapidly growing technology. A major challenge in this field is the need to emergently deploy ECMO for cardiac failure, often with limited time to assess the appropriateness of patients for the intervention. For this reason, we advocate for a multidisciplinary team of experts to guide institutional use of this therapy and the care of patients receiving it. Rigorous patient selection and careful attention to potential complications are key factors in optimizing patient outcomes. Seamless patient transport and clearly defined pathways for transition of care to centers capable of providing heart replacement therapies (e.g., durable ventricular assist device or heart transplantation) are essential to providing the highest level of care for those patients stabilized by ECMO but unable to be weaned from the device. Ultimately, concentration of the most complex care at high-volume centers with advanced cardiac capabilities may be a way to significantly improve the care of this patient population. ? 2018, Springer-Verlag GmbH Germany, part of Springer Nature and ESICM. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042090080&doi=10.1007%2fs00134-018-5064-5&partnerID=40&md5=0e44e9fd02b60ff8dbfc7770fdc98a38 https://scholars.lib.ntu.edu.tw/handle/123456789/433949 |
ISSN: | 0342-4642 | DOI: | 10.1007/s00134-018-5064-5 | SDG/關鍵字: | adult; Article; artificial ventilation; extracorporeal oxygenation; health care delivery; heart center; heart failure; high volume hospital; human; nomenclature; patient safety; patient selection; patient transport; scientific literature; treatment contraindication; treatment indication; cardiogenic shock; heart assist device; heart transplantation; Adult; Extracorporeal Membrane Oxygenation; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Shock, Cardiogenic |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。